19.07 ,
(Committeefor Medicinal Products for Human Use) (European Medicines Agency) Remicade/䮠(), Celltrion Hospira, FirstWord analysis , , ().
Rituxan/() Genentech 蠫Biogen Idec, (22? ), .
-10 2012 ., . Rituxan 6,5 22 Enbrel 7,9 17 Neupogen 1,2 14 Neulasta 4,1 12 Epogen 3,4 10 Herceptin 6,1 9 Avastin 5,5 8 Aranesp 2,7 7 Humira 9,3 7 NovoSeven 1,5 5Rituxan2012?. 6,5? . . , 2013?., 2015?. Rituxan , , Pfizer 蠫Merck&Co..
Enbrel/뮠() 2- 17?, . 2012 . 7,9? ., 2016?. Enbrel , Sandoz ( Novartis) 蠫Daiichi Sankyo.
Herceptin/ (), 9? . Pfizer. Ѡ , 20142015?., 2019?., , . Roche , c Herceptin, Kadcyla ( ) Perjeta ().
Humira/ (, AbbVie) , 2012?. 9,3? . , , . Humira 2018?., 2016?. Ӡ . 2013?. Pfizer I . Humira 蠫Boehringer Ingelheim. 2012?. I .
, .
www.firstwordpharma.com;
www.ema.europa.eu
